CD274 and neoplasm: The tumor cells use mechanisms such as the up-regulation of immune checkpoint signaling program (PD-L1, CTLA-4), the blockage of co-stimulation to activate T cells, and the recruitment of MDSCs, and tumor-associated macrophages to achieve immune suppression [26–28].